Toll-like Receptor (TLR) Ligand Matured Dendritic Cell Vaccination in Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Evaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study of Infrared Imaging of Cutaneous Melanoma
- Status
- COMPLETED
- Phase
- N/A
T-cell Based Immunotherapy for of Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
A Pilot Study of Intraoperative Gamma Camera Imaging During Sentinel Node Biopsy for Melanoma
- Status
- COMPLETED
- Phase
- N/A
Evaluation of the Effects of Local Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Adjuvant Administration on Dendritic Cells in Skin of Melanoma Patients and in Sentinel Lymph Nodes: MEL38
- Status
- COMPLETED
- Phase
- NA
Pilot Study for the Evaluation of the Efficacy of Vaccination With Autologous Tumor Cells Plus Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) - in - Adjuvant, Followed by Systemic Low-dose-interleukin-2 (IL-2) Administration, in Patients With High Risk Melanoma
- Status
- COMPLETED
- Phase
- NA
Sun Exposure and Melanoma in Agricultural Workers
- Status
- COMPLETED
- Phase
- N/A
Collecting Tumor Samples From Patients With Gynecological Tumors
- Status
- COMPLETED
- Phase
- N/A
Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease
- Status
- TERMINATED
- Phase
- N/A
Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Melanoma Molecular Profiling Analysis
- Status
- COMPLETED
- Phase
- N/A
Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study of IFN α2b for Melanoma Patients
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Adjuvant Therapy of Pegylated Interferon- 2b Plus Melanoma Peptide Vaccine
- Status
- COMPLETED
- Phase
- PHASE1